markets · · seekingalpha.com
U.S. IPO Weekly Recap: Trickle Of Biotech Activity Continues Amid Tech Sell-Off
One biotech IPO debuted this week, while four IPOs submitted initial filings, including two sizable biotech filings. One IPO is currently scheduled for the week ahead as investors continue to hold their breath for the year's last potential mega IPO. Street research is expected for two companies in the week ahead, and six lock-up periods will be expiring.
One biotech IPO debuted this week, while four IPOs submitted initial filings, including two sizable biotech filings. One IPO is currently scheduled for the week ahead as investors continue to hold their breath for the year's last potential mega IPO. Street research is expected for two companies in the week ahead, and six lock-up periods will be expiring.
- #LYCA